Home › Viral Infections › Massachusetts › Worcester
Viral Infections clinical trials in Worcester, MA
3 studies for Viral Infections are looking for participants at sites in and around Worcester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
RecruitingPhase 2
- University of Massachusetts, Worcester
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- University of Massachusetts Chan Medical School, Worcester
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- University of Massachusetts Chan Medical School, Worcester
About Viral Infections
Viruses cause familiar infections such as the common cold, but they also cause severe illnesses. Learn more about viral infections and their symptoms.
More about Viral Infections on MedlinePlus
Viral Infections trials in other cities
- Washington, DC12 studies
- Houston, TX6 studies
- Boston, MA6 studies
- Baltimore, MD5 studies
- Hialeah, FL5 studies
- Columbus, OH4 studies
- Dallas, TX4 studies
- Atlanta, GA4 studies
- Cincinnati, OH4 studies
- San Francisco, CA3 studies
- St. Louis, MO3 studies
- Boise, ID3 studies
Other studies in Worcester
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer11 studies
- Cancer (all types)7 studies
- Breast Cancer6 studies
- Schizophrenia5 studies
- Metastatic Cancer5 studies
- Prostate Cancer5 studies
- Ovarian Cancer5 studies
- Major Depressive Disorder5 studies
- Depression5 studies
- Acute Myeloid Leukemia5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.